These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15077264

  • 1. The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis.
    Hansen KE, Cush J, Singhal A, Cooley DA, Cohen S, Patel SR, Genovese M, Sundaramurthy S, Schiff M.
    Arthritis Rheum; 2004 Apr 15; 51(2):228-32. PubMed ID: 15077264
    [Abstract] [Full Text] [Related]

  • 2. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M, Creemers MC, Welsing PM, van Riel PL.
    Rheumatology (Oxford); 2005 Apr 15; 44(4):472-8. PubMed ID: 15598707
    [Abstract] [Full Text] [Related]

  • 3. Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice.
    Perdriger A, Mariette X, Kuntz JL, Brocq O, Kara-Terki R, Loet XL, Cantagrel A, Pavy S, Deslandre CJ, Debiais F, Combe B, Club Rheumatismes et Inflammation.
    J Rheumatol; 2006 May 15; 33(5):865-9. PubMed ID: 16652418
    [Abstract] [Full Text] [Related]

  • 4. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
    Wolfe F, Michaud K, Stephenson B, Doyle J.
    J Rheumatol; 2003 Aug 15; 30(8):1725-32. PubMed ID: 12913927
    [Abstract] [Full Text] [Related]

  • 5. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.
    Cannon GW, Holden WL, Juhaeri J, Dai W, Scarazzini L, Stang P.
    J Rheumatol; 2004 Oct 15; 31(10):1906-11. PubMed ID: 15468352
    [Abstract] [Full Text] [Related]

  • 6. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G.
    J Rheumatol; 2013 Mar 15; 40(3):228-35. PubMed ID: 23322457
    [Abstract] [Full Text] [Related]

  • 7. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V.
    J Rheumatol; 2004 Aug 15; 31(8):1521-31. PubMed ID: 15290730
    [Abstract] [Full Text] [Related]

  • 8. Lefunomide in combination therapy.
    Kalden JR, Smolen JS, Emery P, van Riel PL, Dougados M, Strand CV, Breedveld FC.
    J Rheumatol Suppl; 2004 Jun 15; 71():25-30. PubMed ID: 15170905
    [Abstract] [Full Text] [Related]

  • 9. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E, Spiegel L, Hawkins D, Petty R, Goldsmith D, Schanberg L, Duffy C, Howard P, Strand V.
    Arthritis Rheum; 2005 Feb 15; 52(2):554-62. PubMed ID: 15693001
    [Abstract] [Full Text] [Related]

  • 10. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA, Stamp LK, O'Donnell JL, Savage RL, Chapman PT.
    J Rheumatol; 2007 Nov 15; 34(11):2201-3. PubMed ID: 17937473
    [Abstract] [Full Text] [Related]

  • 11. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis.
    Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka H, Kamatani N, Harigai M, Ryu J, Inoue K, Kondo H, Inokuma S, Ochi T, Koike T.
    Ann Rheum Dis; 2008 Feb 15; 67(2):189-94. PubMed ID: 17644554
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
    Hansen KE, Hildebrand JP, Genovese MC, Cush JJ, Patel S, Cooley DA, Cohen SB, Gangnon RE, Schiff MH.
    J Rheumatol; 2004 Jun 15; 31(6):1098-102. PubMed ID: 15170921
    [Abstract] [Full Text] [Related]

  • 13. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS, Park YW, Park JJ, Kang YM, Nam EJ, Kim SI, Lee JH, Yoo WH, Lee SI.
    Scand J Rheumatol; 2009 Jun 15; 38(1):11-4. PubMed ID: 19191187
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O, Gibofsky A.
    Curr Opin Rheumatol; 2011 May 15; 23(3):288-92. PubMed ID: 21378570
    [Abstract] [Full Text] [Related]

  • 15. Infliximab therapy in established rheumatoid arthritis: an observational study.
    Voulgari PV, Alamanos Y, Nikas SN, Bougias DV, Temekonidis TI, Drosos AA.
    Am J Med; 2005 May 15; 118(5):515-20. PubMed ID: 15866254
    [Abstract] [Full Text] [Related]

  • 16. Rheumatoid arthritis treatment with weekly leflunomide: an open-label study.
    Jaimes-Hernández J, Robles-San Román M, Suárez-Otero R, Dávalos-Zugasti ME, Arroyo-Borrego S.
    J Rheumatol; 2004 Feb 15; 31(2):235-7. PubMed ID: 14760790
    [Abstract] [Full Text] [Related]

  • 17. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M, Emery P, Lemmel EM, Zerbini CA, Brin S, van Riel P.
    Ann Rheum Dis; 2005 Jan 15; 64(1):44-51. PubMed ID: 15271770
    [Abstract] [Full Text] [Related]

  • 18. Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
    Karanikolas G, Charalambopoulos D, Andrianakos A, Antoniades C, Katsilambros N.
    J Rheumatol; 2006 Mar 15; 33(3):486-9. PubMed ID: 16511917
    [Abstract] [Full Text] [Related]

  • 19. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL, Watson KD, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register.
    Rheumatology (Oxford); 2006 Dec 15; 45(12):1558-65. PubMed ID: 16705046
    [Abstract] [Full Text] [Related]

  • 20. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov 15; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.